» Articles » PMID: 9425452

Foamy Virus Vectors for Suicide Gene Therapy

Overview
Journal Gene Ther
Date 1998 Jan 13
PMID 9425452
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

To improve the delivery of so-called suicide genes into tumors, recombinant retroviruses were constructed by inserting the herpes virus type 1 (HSV-1) thymidine kinase (tk), the E. coli cytosine deaminase (cd) and polynucleoside phosphorylase (pnp), or the jellyfish gene for the green fluorescent protein (gfp) into a foamy virus (FV)-derived replication-competent vector (pFOV-7). Expression and stability of the inserted foreign gene was analyzed by immunoblot and polymerase chain reaction (PCR). The functionality of the suicide genes was determined by a metabolic assay on virus vector infected cells and treatment with the respective prodrugs. In terms of vector stability and effectiveness of specific cell killing a virus transducing the pnp gene (FOV-7/pnp) was superior to those using the other two suicide genes. FOV-7/pnp is a candidate virus for suicide gene delivery into solid tumors.

Citing Articles

Evaluation of the stability and intratumoral delivery of foreign transgenes encoded by an oncolytic Foamy Virus vector.

Budzik K, Nace R, Ikeda Y, Russell S Cancer Gene Ther. 2022; 29(8-9):1240-1251.

PMID: 35145270 PMC: 9363555. DOI: 10.1038/s41417-022-00431-y.


Intratumoral generation of 2-fluoroadenine to treat solid malignancies of the head and neck.

Behbahani T, Rosenthal E, Parker W, Sorscher E Head Neck. 2019; 41(6):1979-1983.

PMID: 30633420 PMC: 6531318. DOI: 10.1002/hed.25627.


Use of E. coli Purine Nucleoside Phosphorylase in the Treatment of Solid Tumors.

Parker W, Sorscher E Curr Pharm Des. 2017; .

PMID: 29119917 PMC: 6224313. DOI: 10.2174/1381612823666171109101851.


Progresses towards safe and efficient gene therapy vectors.

Chira S, Jackson C, Oprea I, Ozturk F, Pepper M, Diaconu I Oncotarget. 2015; 6(31):30675-703.

PMID: 26362400 PMC: 4741561. DOI: 10.18632/oncotarget.5169.


Phase I dose-escalating trial of Escherichia coli purine nucleoside phosphorylase and fludarabine gene therapy for advanced solid tumors.

Rosenthal E, Chung T, Parker W, Allan P, Clemons L, Lowman D Ann Oncol. 2015; 26(7):1481-7.

PMID: 25899782 PMC: 4560028. DOI: 10.1093/annonc/mdv196.